Hyderabad Telangana, India

Jangalgar Tirupathy Reddy

This inventor holds 13 USPTO granted patents, primarily in Triazine Compounds. Top assignees: Reddy US Therapeutics, Inc., Dr. Reddy's Laboratories, Incorporated, Reddy U5 Therapeutics, Inc.. Active years: 2006-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jangalgar Tirupathy Reddy. Retrieved from https://idiyas.com/inventor/jangalgar-tirupathy-reddy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 10.1

ph-index = 5

Forward Citations = 149(Granted Patents)


Location History:

  • Hyderabad, IN (2006 - 2008)
  • Miyapur, IN (2008)

Company Filing History:


Years Active: 2006-2008

Loading Chart...
Areas of Expertise:
Triazine Compounds
Medical Devices
Compositions
Novel Compounds
Optically Pure Isomers
Analog Compounds
Preparation Process
Pharmaceutical Applications
Chemical Methods
Compositions Thereof
13 patents (USPTO):Explore Patents

Title: Jangalgar Tirupathy Reddy: Innovating Medical Devices and Triazine Compounds

Introduction:

In the world of medical innovations and patenting, Jangalgar Tirupathy Reddy is a skilled and accomplished inventor based in Hyderabad, India. With a strong focus on designing medical devices and compounds, he has made significant contributions to the field. This article will delve into his latest patents, career highlights, collaborations, and commend his valuable contributions to the industry.

Latest Patents:

Jangalgar Tirupathy Reddy holds an impressive portfolio of 13 patents, showcasing his expertise and inventive spirit. Among his notable latest patents are:

1. Medical devices employing triazine compounds and compositions thereof:

This patent revolves around methods, compounds, and compositions that aim to address pathophysiological conditions resulting from inflammatory responses. Specifically, it focuses on compounds that inhibit or block glycated protein-induced signaling-associated inflammatory responses in endothelial cells. Additionally, this invention relates to medical devices, such as stents, incorporating these compounds.

2. Triazine compounds and their analogs, compositions, and methods:

This patent highlights the development of triazine compounds and their analogs and derivatives. These compounds, along with the compositions and methods described in the patent, are beneficial for treating various pathophysiological conditions arising from inflammatory responses, inhibiting smooth muscle proliferation, and managing vascular occlusive conditions such as restenosis and atherosclerosis.

Career Highlights:

Jangalgar Tirupathy Reddy has made significant contributions to the field of medical innovations throughout his remarkable career. Notably, he has worked with esteemed companies such as Reddy US Therapeutics, Inc. and Dr. Reddy's Laboratories, Incorporated. At these organizations, he has showcased his expertise and played a crucial role in developing novel medical devices and compounds.

Collaborations:

Collaboration plays a vital role in the realm of innovation, and Jangalgar Tirupathy Reddy has been fortunate to work with some brilliant minds in his field. Notably, he has collaborated with Richard T Timmer and Christopher W Alexander, both esteemed professionals, in various projects. These collaborations have undoubtedly enriched his work, adding diversity and depth to his innovative projects.

Conclusion:

Jangalgar Tirupathy Reddy's journey in the field of medical innovations and patents is nothing short of inspiring. With his extensive knowledge and expertise, he has focused on developing medical devices and compounds that address pathophysiological conditions arising from inflammatory responses. His remarkable patents, career highlights, and collaborations truly reflect his dedication and immense contribution to the field. Jangalgar Tirupathy Reddy's work continues to pave the way for advancements in medical technology, benefiting individuals worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…